Global Aprepitant Capsules Market Research Report 2025

Publication ID:

PB502255495

Publication Date:

February 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Aprepitant Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Aprepitant capsules are widely used for the prevention of nausea and vomiting during both the induction and subsequent phases of chemotherapy. With the continuous evolution of the oncology field, Aprepitant capsules have solidified their position in the market, leading to a gradual expansion of its market size. Its outstanding clinical performance has resulted in sustained sales growth, establishing it as a key player in the management of nausea and vomiting. Furthermore, as research into supportive therapies for cancer treatment advances, Aprepitant capsules hold the potential for further application and development in a broader spectrum of nausea and vomiting prevention, ultimately offering enhanced quality of life for patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aprepitant Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant Capsules.
The Aprepitant Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aprepitant Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprepitant Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma
Segment by Type
80mg
125mg
Other
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprepitant Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aprepitant Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Aprepitant Capsules Market Overview
1.1 Product Definition
1.2 Aprepitant Capsules by Type
1.2.1 Global Aprepitant Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 80mg
1.2.3 125mg
1.2.4 Other
1.3 Aprepitant Capsules by Application
1.3.1 Global Aprepitant Capsules Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Aprepitant Capsules Market Size Estimates and Forecasts
1.4.1 Global Aprepitant Capsules Revenue 2020-2031
1.4.2 Global Aprepitant Capsules Sales 2020-2031
1.4.3 Global Aprepitant Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Aprepitant Capsules Market Competition by Manufacturers
2.1 Global Aprepitant Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Aprepitant Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Aprepitant Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Aprepitant Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aprepitant Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aprepitant Capsules, Product Type & Application
2.7 Global Key Manufacturers of Aprepitant Capsules, Date of Enter into This Industry
2.8 Global Aprepitant Capsules Market Competitive Situation and Trends
2.8.1 Global Aprepitant Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Aprepitant Capsules Players Market Share by Revenue
2.8.3 Global Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aprepitant Capsules Market Scenario by Region
3.1 Global Aprepitant Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Aprepitant Capsules Sales by Region: 2020-2031
3.2.1 Global Aprepitant Capsules Sales by Region: 2020-2025
3.2.2 Global Aprepitant Capsules Sales by Region: 2026-2031
3.3 Global Aprepitant Capsules Revenue by Region: 2020-2031
3.3.1 Global Aprepitant Capsules Revenue by Region: 2020-2025
3.3.2 Global Aprepitant Capsules Revenue by Region: 2026-2031
3.4 North America Aprepitant Capsules Market Facts & Figures by Country
3.4.1 North America Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Aprepitant Capsules Sales by Country (2020-2031)
3.4.3 North America Aprepitant Capsules Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aprepitant Capsules Market Facts & Figures by Country
3.5.1 Europe Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Aprepitant Capsules Sales by Country (2020-2031)
3.5.3 Europe Aprepitant Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aprepitant Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Aprepitant Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Aprepitant Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Aprepitant Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aprepitant Capsules Market Facts & Figures by Country
3.7.1 Latin America Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Aprepitant Capsules Sales by Country (2020-2031)
3.7.3 Latin America Aprepitant Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aprepitant Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Aprepitant Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Aprepitant Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Aprepitant Capsules Sales by Type (2020-2031)
4.1.1 Global Aprepitant Capsules Sales by Type (2020-2025)
4.1.2 Global Aprepitant Capsules Sales by Type (2026-2031)
4.1.3 Global Aprepitant Capsules Sales Market Share by Type (2020-2031)
4.2 Global Aprepitant Capsules Revenue by Type (2020-2031)
4.2.1 Global Aprepitant Capsules Revenue by Type (2020-2025)
4.2.2 Global Aprepitant Capsules Revenue by Type (2026-2031)
4.2.3 Global Aprepitant Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Aprepitant Capsules Price by Type (2020-2031)
5 Segment by Application
5.1 Global Aprepitant Capsules Sales by Application (2020-2031)
5.1.1 Global Aprepitant Capsules Sales by Application (2020-2025)
5.1.2 Global Aprepitant Capsules Sales by Application (2026-2031)
5.1.3 Global Aprepitant Capsules Sales Market Share by Application (2020-2031)
5.2 Global Aprepitant Capsules Revenue by Application (2020-2031)
5.2.1 Global Aprepitant Capsules Revenue by Application (2020-2025)
5.2.2 Global Aprepitant Capsules Revenue by Application (2026-2031)
5.2.3 Global Aprepitant Capsules Revenue Market Share by Application (2020-2031)
5.3 Global Aprepitant Capsules Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Aprepitant Capsules Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Company Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sandoz Aprepitant Capsules Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Company Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Glenmark Pharmaceuticals Aprepitant Capsules Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 Chia Tai Tianqing Pharmaceutical Group
6.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.4.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.4.3 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Portfolio
6.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.5 Qilu Pharmaceutical
6.5.1 Qilu Pharmaceutical Company Information
6.5.2 Qilu Pharmaceutical Description and Business Overview
6.5.3 Qilu Pharmaceutical Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qilu Pharmaceutical Aprepitant Capsules Product Portfolio
6.5.5 Qilu Pharmaceutical Recent Developments/Updates
6.6 Camber Pharma
6.6.1 Camber Pharma Company Information
6.6.2 Camber Pharma Description and Business Overview
6.6.3 Camber Pharma Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Camber Pharma Aprepitant Capsules Product Portfolio
6.6.5 Camber Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aprepitant Capsules Industry Chain Analysis
7.2 Aprepitant Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aprepitant Capsules Production Mode & Process Analysis
7.4 Aprepitant Capsules Sales and Marketing
7.4.1 Aprepitant Capsules Sales Channels
7.4.2 Aprepitant Capsules Distributors
7.5 Aprepitant Capsules Customer Analysis
8 Aprepitant Capsules Market Dynamics
8.1 Aprepitant Capsules Industry Trends
8.2 Aprepitant Capsules Market Drivers
8.3 Aprepitant Capsules Market Challenges
8.4 Aprepitant Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂